Legislative Action: Information for Legislators Toolkit & Handouts

legislative Toolkit & Handouts aspire pans pandas cvr

Legislative Action: Information for Legislators Toolkit & Handouts


Download Legislative Toolkit

Legislative Action: Information for Legislators Toolkit

Download ASPIRE’s PANS/PANDAS Legislative Action: Information for Legislators Toolkit. 

This Legislative Toolkit covers topics including:

  • What are PANS/PANDAS
  • Overview of Diagnosis & Treatment
  • PANS/PANDAS Legislative Action
  • Current Landscape of PANS/PANDAS
  • Impact of of PANS/PANDAS
  • On Treatment & The Use of IVIG
  • Why Passage of Legislation is Critical
  • Passed Insurance Bills

Revised: October 2025


Download PANS/PANDAS Legislative Information – 1 pager

PANS/PANDAS Legislative Information


Download (PDF) Mandated Insurance Coverage for PANS/PANDAS: A Legislative Overview

Mandated Insurance Coverage for PANS and PANDAS: A Legislative Overview


Download (PDF) The Need for Mandated Insurance Coverage for PANS/PANDAS

The Need for Insurance Coverage for PANS/PANDAS

 


Download (PDF) ASPIRE’s Statement on Aetna’s Policy

ASPIRE Aetna Policy Legislative Statement


Download (PDF) ASPIRE’s Explainer on RI PANS PANDAS Insurance Report

Mandated RI PANS PANDAS Insurance Report


Download (PDF) ASPIRE Legislative Map

ASPIRE Legislative Map

ASPIRE PANS PANDAS Legislative Map

 

 

 

 


Read Article: A Chat About Legislative Advocacy: Your Story Matters

A Chat About Legislative Advocacy


Return to ASPIRE Legislative Resources

 

 

 

2 comments to Legislative Action: Information for Legislators Toolkit & Handouts

  1. Karina Gamboa
    October 4, 2024

    Does my child need to wait until January 2025 to get IVIG approved?

    Reply
    • Gabriella True
      October 4, 2024

      If your child is in Colorado or California, then to get IVIG approved for PANS, then yes. Your provider may be able to prove medical necessity under another diagnosis your child may have like AE, an immunodeficiency or CDIP.

      Reply

Leave a comment